Prahlad R. Singh - 04 Feb 2026 Form 4 Insider Report for REVVITY, INC. (RVTY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Feb 2026, 16:05:07 UTC
Prior SEC filing
31 Oct 2025
Next SEC filing
19 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
John L. Healy (POA on file) for Prahlad R. Singh

Key filing fact

Prahlad R. Singh filed Form 4 for REVVITY, INC. (RVTY) on 06 Feb 2026.

Key facts

  • This page summarizes Prahlad R. Singh's Form 4 filing for REVVITY, INC. (RVTY).
  • 10 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 06 Feb 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 31 Oct 2025.
  • Current net transaction value: -$553,227.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001684136 Primary reporting owner

Singh Prahlad R.

Relationship
President, Chief Executive Officer and Director, Director
Address
77 4TH AVENUE, WALTHAM
Signature
John L. Healy (POA on file) for Prahlad R. Singh
Signature date
06 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVTY transaction

Common Stock

Tax liability

Transaction value
$345,966
Shares
-3,421
Change %
-3.5%
Price
$101.13
Shares after
93,417
Date
04 Feb 2026
Ownership
Direct
Footnotes
F1, F2
RVTY transaction

Common Stock

Award

Transaction value
$0
Shares
+26,796
Change %
+29%
Price
$0.000000
Shares after
120,213
Date
04 Feb 2026
Ownership
Direct
Footnotes
F3
RVTY transaction

Common Stock

Options Exercise

Transaction value
$2,350,597
Shares
+25,525
Change %
+21%
Price
$92.09
Shares after
145,738
Date
05 Feb 2026
Ownership
Direct
RVTY transaction

Common Stock

Sale

Transaction value
$129,419
Shares
-1,307
Change %
-0.9%
Price
$99.02
Shares after
144,431
Date
05 Feb 2026
Ownership
Direct
Footnotes
F4, F5
RVTY transaction

Common Stock

Sale

Transaction value
$1,213,116
Shares
-12,186
Change %
-8.4%
Price
$99.55
Shares after
132,245
Date
05 Feb 2026
Ownership
Direct
Footnotes
F4, F6
RVTY transaction

Common Stock

Sale

Transaction value
$793,468
Shares
-7,885
Change %
-6%
Price
$100.63
Shares after
124,360
Date
05 Feb 2026
Ownership
Direct
Footnotes
F4, F7
RVTY transaction

Common Stock

Sale

Transaction value
$312,365
Shares
-3,079
Change %
-2.5%
Price
$101.45
Shares after
121,281
Date
05 Feb 2026
Ownership
Direct
Footnotes
F4, F8
RVTY transaction

Common Stock

Sale

Transaction value
$109,491
Shares
-1,068
Change %
-0.88%
Price
$102.52
Shares after
120,213
Date
05 Feb 2026
Ownership
Direct
Footnotes
F4, F9
RVTY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
46,583
Date
04 Feb 2026
Ownership
By Singh Family Trust of 2021
Footnotes
F10

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RVTY transaction Derivative

NQ Stock Option (right to buy)

Award

Transaction value
$0
Shares
+76,647
Change %
Price
$0.000000
Shares after
76,647
Date
04 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
76,647
Exercise price
$103.40
Footnotes
F11
RVTY transaction Derivative

NQ Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-25,525
Change %
-100%
Price
$0.000000
Shares after
0
Date
05 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,525
Exercise price
$92.09
Footnotes
F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 12 footnotes

Footnote F1

The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.

Footnote F2

These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement.

Footnote F3

Shares are time-based restricted stock units that are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.

Footnote F4

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025.

Footnote F5

The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.07. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F6

The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.10 to $100.08. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F7

The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.10 to $101.09. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F8

The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $101.12 to $101.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F9

The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

Footnote F10

Securities held in an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F11

This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.

Footnote F12

This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted.

SEC remarks

President, Chief Executive Officer and Director

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .